Igyxos
Igyxos is a biotech startup developing a new treatment for female and male infertility that works by shifting hormal imbalances.
Nouzilly, Francewww.igyxos.com ↗
Total raised
€7.5M
€7,500,000
Funding rounds
1
Investors
1
distinct backers
Active since
2018-12
latest 2018-12
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood16
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-01-01 | Series A | €7.5M | Bpifrance | View deal → |
Investors
1Related news
Similar companies
same sector or country- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Mistral AI€3.5BFrance · AI
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- ContentSquare€1.3BFrance · Software